OCGN Q4 2019 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

$12M

EPS (Diluted)

$0.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$164,075

Balance Sheet

Total Assets

$17M

Total Liabilities

$6M

Stockholders' Equity

$11M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$10M	+56.1%
Net Income	$12M	-$818,000	+1613.7%